[HTML][HTML] Human iPSC banking: barriers and opportunities

CY Huang, CL Liu, CY Ting, YT Chiu… - Journal of biomedical …, 2019 - Springer
The introduction of induced pluripotent stem cells (iPSCs) has opened up the potential for
personalized cell therapies and ushered in new opportunities for regenerative medicine …

[HTML][HTML] Fit-for-all iPSC-derived cell therapies and their evaluation in humanized mice with NK cell immunity

C Flahou, T Morishima, H Takizawa… - Frontiers in …, 2021 - frontiersin.org
Human induced pluripotent stem cells (iPSCs) can be limitlessly expanded and
differentiated into almost all cell types. Moreover, they are amenable to gene manipulation …

S1P–S1PR2 axis mediates homing of muse cells into damaged heart for long-lasting tissue repair and functional recovery after acute myocardial infarction

Y Yamada, S Wakao, Y Kushida… - Circulation …, 2018 - Am Heart Assoc
Rationale: Multilineage-differentiating stress enduring (Muse) cells, pluripotent marker stage-
specific embryonic antigen-3+ cells, are nontumorigenic endogenous pluripotent-like stem …

[HTML][HTML] Interactions between HLA-G and HLA-E in physiological and pathological conditions

F Morandi, V Pistoia - Frontiers in immunology, 2014 - frontiersin.org
HLA-G and HLA-E are immunoregulatory molecules that belong to HLA-Ib family. The role of
these molecules in the control of the immune response has been extensively analyzed, both …

[HTML][HTML] Human iPS cell-derived insulin producing cells form vascularized organoids under the kidney capsules of diabetic mice

SP Raikwar, EM Kim, WI Sivitz, C Allamargot… - PloS one, 2015 - journals.plos.org
Type 1 diabetes (T1D) is caused by autoimmune disease that leads to the destruction of
pancreatic β-cells. Transplantation of cadaveric pancreatic organs or pancreatic islets can …

Immunogenicity and tumorigenicity of pluripotent stem cells and their derivatives: genetic and epigenetic perspectives

Y Tan, S Ooi, L Wang - Current stem cell research & therapy, 2014 - ingentaconnect.com
One aim of stem cell-based therapy is to utilize pluripotent stem cells (PSCs) as a
supplementary source of cells to repair or replace tissues or organs that have ceased to …

[HTML][HTML] Stem cell therapy for inflammatory bowel disease

K Nagaishi, Y Arimura, M Fujimiya - Journal of Gastroenterology, 2015 - Springer
Inflammatory bowel disease (IBD) could be curable by “immune rest” and correction of the
genetic predisposition inherent in allogeneic hematopoietic stem cell transplantation …

[HTML][HTML] Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic β cells

GS Manzar, EM Kim, N Zavazava - Journal of Biological Chemistry, 2017 - ASBMB
Type 1 diabetes (T1D) can be managed by transplanting either the whole pancreas or
isolated pancreatic islets. However, cadaveric pancreas is scarcely available for clinical use …

Muse cells are endogenous reparative stem cells

Y Kushida, S Wakao, M Dezawa - Muse Cells: Endogenous Reparative …, 2018 - Springer
The dynamics and actions of Muse cells at a time of physical crisis are unique and highly
remarkable compared with other stem cell types. When the living body is in a steady state …

[HTML][HTML] Generation of human liver organoids from pluripotent stem cell-derived hepatic endoderms

K Kulkeaw, A Tubsuwan, N Tongkrajang… - PeerJ, 2020 - peerj.com
Background The use of a personalized liver organoid derived from human-induced
pluripotent stem cells (HuiPSCs) is advancing the use of in vitro disease models for the …